Advertisement

Topics

BioMed Capital Group Ltd. Company Profile

11:13 EDT 22nd September 2017 | BioPortfolio

BioMed principals and affiliates understand the strategic factors that drive future performance, including: Competition and competitive advantages Technology as related to markets served Capital requirements
Value proposition BioMed incorporates thorough and well developed planning methods to identify critical factors, map out and identify strategic alternatives. Importantly, we are fully committed to implement the plan.

Location

Darby Terrace
Livingston
New Jersey
07039
United States of America

Contact

Phone: (973) 994-3908 ·
Fax: (973) 994-1782
Email: ishigami@stii.jp


News Articles [1406 Associated News Articles listed on BioPortfolio]

San Antonio Biomedical Group Awards Miami Healthcare Researcher

San Antonio — The San Antonio bioscience advocacy group BioMed SA is giving its annual innovation award to Leonard Pinchuk, a scientific researcher in Miami who has co-founded or incubated 10 c...

LA BioMed researcher honored for contributions to medicine

(LA BioMed) The Medical Mycology Society of the Americas has honored John E. "Jack" Edwards, Jr., MD, an LA BioMed lead researcher, as the winner of the 2017 Rhoda Benham Award

Shanghai's Harbour BioMed in $81 Million Deal for Two HanAll Biologic Drugs

Harbour BioMed, a China-US biopharma, will collaborate with Korea's HanAll Biopharma to develop two of HanAll's novel biologics in Greater China. HanAll will receive up to $81 million in a combination...

Anaconda raises €15mm in Series A round

Anaconda BioMed SL (neuro-thrombectomy system for acute ischemic stroke (AIS)) raised €15mm ($16.8mm) in a Series A round co-led by new investors Ysios Capital and Omega Funds, along with returning ...

Q BioMed Inc. Closes $3,050,390 Equity Financing

NEW YORK, August 2, 2017 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) is pleased to announce the closing of a $3,050,390 equity financing. The financing with a small group of accredited investors p...

Q BioMed partners with Sphaera for pediatric developmental nonverbal disorder

Q BioMed (QBIO), a biotechnology acceleration company, announced a partnership with Sphaera Pharma to develop a new and proprietary analog of QBM-001 for pediatric developmental nonverbal disorder. &#...

HanAll Biopharma and Harbour BioMed link up on biologicals development in Greater China

South Korea’s HanAll Biopharma (009420: KS) and Massachusetts, USA-based Harbour BioMed have entered…

GL Capital-led consortium to buy SciClone Pharmaceuticals

A consortium featuring entities affiliated with GL Capital Management GP, Bank of China Group Investment (BOCGI), CDH Investments, Ascendent Capital Partners and Boying will acquire all the outstandin...

PubMed Articles [2830 Associated PubMed Articles listed on BioPortfolio]

A Tale of Two Towns: A Comparative Study Exploring the Possibilities and Pitfalls of Social Capital among People Seeking Recovery from Substance Misuse.

Social capital has become an influential concept in debating and understanding the modern world. Within the drug and alcohol sector, the concept of 'recovery capital' has gained traction with research...

Examination of the influence of social capital on depression in fragile families.

While it appears that social capital has a positive effect on mental health, most studies have been cross-sectional in nature and/or employ weak measures of social capital or mental health. Even less ...

Twenty years of social capital and health research: a glossary.

Research on social capital in public health is approaching its 20th anniversary. Over this period, there have been rich and productive debates on the definition, measurement and importance of social c...

Perceptions of community, social capital, and how they affect self-reported health: a multilevel analysis.

The link between social capital and self-reported health has been widely explored. On the other hand, we know less about the relationship between social capital, community socioeconomic characteristic...

The intersection of class origin and immigration background in structuring social capital: the role of transnational ties.

The study investigates inequalities in access to social capital based on social class origin and immigration background and examines the role of transnational ties in explaining these differences. Soc...

Clinical Trials [3161 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Amendment of rTSST-1 Variant Vaccine Phase 1 First-in-man Trail

Toxic Shock Syndrome (TSS) a severe condition with high morbidity and mortality results from the hosts overwhelming inflammatory response and cytokine storm. Staphylococcal superantigen to...

Social Inequalities in Emergency Call and Emergency Response Patterns

Background: Inequality in access to healthcare is a challenge internationally. Despite that medical emergency calls can be considered as access point to pre-hospital emergency care and ...

Reproducibility of Malaria Challenge in Healthy Volunteers

This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the wel...

Color Stability of NeoMTA Pulpotomized Primary Teeth

This randomized control study will use 15 pediatric subjects selected from the patient population in the pediatric dental clinic at Children's Medical Center Dental Clinic (CMC Dental Clin...

Companies [2589 Associated Companies listed on BioPortfolio]

BioMed Capital Group Ltd.

BioMed principals and affiliates understand the strategic factors that drive future performance, including: Competition and competitive advantages Technology as related to markets served Capital requ...

Merlin BioMed Group

Merlin BioMed Group is a Registered Investment Advisor which invests globally in public and private healthcare companies, and is among the most successful healthcare asset management companies in the ...

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmun...

BioMed Central Ltd

BioMed Central is an independent publishing house committed to providing immediate open access to peer-reviewed biomedical researchAll original research articles published by BioMed Central are made f...

Biomed

Biomed AG wurde 1951 in Zürich gegründet und hat sich seither als Handelsunternehmen für pharmazeutische Produkte im Schweizer Markt etabliert. Biomed ist spezialisiert auf den Handel mit rezeptpfl...

More Information about "BioMed Capital Group Ltd." on BioPortfolio

We have published hundreds of BioMed Capital Group Ltd. news stories on BioPortfolio along with dozens of BioMed Capital Group Ltd. Clinical Trials and PubMed Articles about BioMed Capital Group Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMed Capital Group Ltd. Companies in our database. You can also find out about relevant BioMed Capital Group Ltd. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record